HK1180298A1 - 泛醇基二十二碳六烯酸酯及其治療和預防心血管疾病的用途 - Google Patents
泛醇基二十二碳六烯酸酯及其治療和預防心血管疾病的用途Info
- Publication number
- HK1180298A1 HK1180298A1 HK13107421.9A HK13107421A HK1180298A1 HK 1180298 A1 HK1180298 A1 HK 1180298A1 HK 13107421 A HK13107421 A HK 13107421A HK 1180298 A1 HK1180298 A1 HK 1180298A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- docosahexaeneoate
- panthenyl
- treating
- cardiovascular diseases
- preventing cardiovascular
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1056560A FR2963790B1 (fr) | 2010-08-11 | 2010-08-11 | Docosahexaeneoate de panthenyle et son utilisation dans le traitement et la prevention des maladies cardiovasculaires |
PCT/EP2011/063854 WO2012020094A1 (en) | 2010-08-11 | 2011-08-11 | Panthenyl docosahexaeneoate and its use for treating and preventing cardiovascular diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1180298A1 true HK1180298A1 (zh) | 2013-10-18 |
Family
ID=43754935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13107421.9A HK1180298A1 (zh) | 2010-08-11 | 2013-06-25 | 泛醇基二十二碳六烯酸酯及其治療和預防心血管疾病的用途 |
Country Status (29)
Country | Link |
---|---|
US (2) | US20130137768A1 (zh) |
EP (1) | EP2603486B1 (zh) |
JP (1) | JP5960695B2 (zh) |
KR (1) | KR20140031830A (zh) |
CN (1) | CN103025707B (zh) |
AR (1) | AR082594A1 (zh) |
AU (1) | AU2011288410B2 (zh) |
BR (1) | BR112013003149A2 (zh) |
CA (1) | CA2806154A1 (zh) |
CY (1) | CY1116088T1 (zh) |
DK (1) | DK2603486T3 (zh) |
ES (1) | ES2531437T3 (zh) |
FR (1) | FR2963790B1 (zh) |
HK (1) | HK1180298A1 (zh) |
HR (1) | HRP20150265T1 (zh) |
HU (1) | HUE024560T2 (zh) |
IL (1) | IL224632A (zh) |
MA (1) | MA34480B1 (zh) |
MX (1) | MX2013001506A (zh) |
MY (1) | MY166065A (zh) |
NZ (1) | NZ607836A (zh) |
PL (1) | PL2603486T3 (zh) |
PT (1) | PT2603486E (zh) |
RS (1) | RS53896B1 (zh) |
RU (1) | RU2593203C2 (zh) |
SI (1) | SI2603486T1 (zh) |
TW (1) | TWI555528B (zh) |
UA (1) | UA109551C2 (zh) |
WO (1) | WO2012020094A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102011014386A1 (de) * | 2011-03-11 | 2012-09-13 | Hemoteq Ag | Endoprothese mit einer Wirkstoffbeschichtung |
FR2998479B1 (fr) * | 2012-11-27 | 2017-04-28 | Pf Medicament | Utilisation d'un ester de dha pour le traitement prophylactique et/ou curatif de la drepanocytose |
KR102091211B1 (ko) | 2014-07-30 | 2020-03-19 | 가부시키가이샤 아에타스 파루마 | 1,4-벤조티아제핀-1-옥사이드 유도체의 광학 이성질체, 및 그것을 사용한 의약 조성물 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR955612A (zh) | 1950-01-18 | |||
NL133049C (zh) * | 1966-02-24 | |||
ITMI20022511A1 (it) | 2002-11-26 | 2004-05-27 | Victorix Assets Ltd | Uso di composizioni farmaceutiche contenenti esteri etilici di acidi poliinsaturi omega-3 nella orevenzione della fibrillazione atriale. |
FR2902659A1 (fr) * | 2006-06-23 | 2007-12-28 | Pierre Fabre Medicament Sa | Ester de dha et son utilisation dans le traitement et la prevention des maladies cardiovasculaires |
FR2949063B1 (fr) * | 2009-08-11 | 2011-09-30 | Pf Medicament | Composition pharmaceutique comprenant un ester de dha destinee a etre administree par voie parenterale |
-
2010
- 2010-08-11 FR FR1056560A patent/FR2963790B1/fr active Active
-
2011
- 2011-08-01 TW TW100127261A patent/TWI555528B/zh not_active IP Right Cessation
- 2011-08-08 AR ARP110102874A patent/AR082594A1/es unknown
- 2011-08-11 MX MX2013001506A patent/MX2013001506A/es unknown
- 2011-08-11 ES ES11743536.2T patent/ES2531437T3/es active Active
- 2011-08-11 NZ NZ607836A patent/NZ607836A/en not_active IP Right Cessation
- 2011-08-11 SI SI201130418T patent/SI2603486T1/sl unknown
- 2011-08-11 CA CA2806154A patent/CA2806154A1/en not_active Abandoned
- 2011-08-11 PL PL11743536T patent/PL2603486T3/pl unknown
- 2011-08-11 JP JP2013523623A patent/JP5960695B2/ja not_active Expired - Fee Related
- 2011-08-11 US US13/816,048 patent/US20130137768A1/en not_active Abandoned
- 2011-08-11 PT PT117435362T patent/PT2603486E/pt unknown
- 2011-08-11 EP EP11743536.2A patent/EP2603486B1/en not_active Not-in-force
- 2011-08-11 KR KR1020137004509A patent/KR20140031830A/ko not_active Application Discontinuation
- 2011-08-11 BR BR112013003149A patent/BR112013003149A2/pt active Search and Examination
- 2011-08-11 HU HUE11743536A patent/HUE024560T2/hu unknown
- 2011-08-11 RU RU2013110131/04A patent/RU2593203C2/ru not_active IP Right Cessation
- 2011-08-11 WO PCT/EP2011/063854 patent/WO2012020094A1/en active Application Filing
- 2011-08-11 DK DK11743536.2T patent/DK2603486T3/en active
- 2011-08-11 CN CN201180036873.2A patent/CN103025707B/zh not_active Expired - Fee Related
- 2011-08-11 MY MYPI2013000417A patent/MY166065A/en unknown
- 2011-08-11 AU AU2011288410A patent/AU2011288410B2/en not_active Ceased
- 2011-08-11 RS RS20150175A patent/RS53896B1/en unknown
- 2011-08-11 MA MA35677A patent/MA34480B1/fr unknown
- 2011-11-08 UA UAA201303028A patent/UA109551C2/uk unknown
-
2013
- 2013-02-07 IL IL224632A patent/IL224632A/en not_active IP Right Cessation
- 2013-06-25 HK HK13107421.9A patent/HK1180298A1/zh not_active IP Right Cessation
-
2015
- 2015-03-06 CY CY20151100233T patent/CY1116088T1/el unknown
- 2015-03-10 HR HRP20150265AT patent/HRP20150265T1/hr unknown
- 2015-06-24 US US14/748,538 patent/US20150291507A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2542060A4 (en) | COMPOSITIONS AND METHODS FOR TREATMENT AND / OR PREVENTION OF CARDIOVASCULAR DISEASES | |
EP2603199A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | |
GB2478595B (en) | Phytocannabinoids in the treatment of glioma | |
DK2608777T3 (en) | Compositions and Methods for Cardiac Therapy | |
HK1187049A1 (zh) | 雙芳基連接的芳基三唑酮及其用途 | |
EP2655334A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES | |
IL222702A0 (en) | Incontinence treatment | |
EP2611496A4 (en) | Methods of Treatment | |
PL2652193T3 (pl) | Obróbka | |
EP2627331A4 (en) | METHODS OF TREATING HYPERURICEMIA AND RELATED DISEASES | |
HK1195736A1 (zh) | 放射免疫偶聯物和它們的用途 | |
EP2544655A4 (en) | COMPOSITIONS AND METHODS FOR TREATING SKIN | |
SG10201500124VA (en) | Methods and Compositions for Treating Cancer | |
EP2575825A4 (en) | COMPOSITIONS AND METHODS FOR TREATING DEPRESSION | |
HK1193379A1 (zh) | 修復組合物和處理方法 | |
HK1183766A1 (zh) | 用於治療瘀傷的組合物和方法 | |
EP2593111A4 (en) | NEW COMPOUNDS FOR THE TREATMENT OF CANCER AND OTHER DISEASES | |
IL225483A0 (en) | The compositions and methods for the treatment of neoplasia | |
GB201013573D0 (en) | Treatment | |
HK1180298A1 (zh) | 泛醇基二十二碳六烯酸酯及其治療和預防心血管疾病的用途 | |
EP2582384A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER | |
EP2537031A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | |
GB201718726D0 (en) | Phytocannabinoids in the treatment of cancer | |
GB201014097D0 (en) | Treatment | |
GB201003741D0 (en) | Methods and therapeutic compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190809 |